| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6ffa273d33fe5deecb6ff916888ea066
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8dbdfc93841b3d731fbab7ea48b412a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a9e9ce63eb0bbf3658453fb50a6d9b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-52 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52 |
| filingDate |
1993-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cbe0bae86d88df2804745bfdbefa4ba |
| publicationDate |
1994-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9403173-A1 |
| titleOfInvention |
Use of 8-(3-oxocyclopentyl)-1,3-dipropyl-7h-purine-2,6-dione for the symptomatic treatment of cystic fibrosis |
| abstract |
The invention concerns the use of 8-(3-oxocyclopentyl)-1,3-dipropyl-7H-purine-2,6-dione. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9938532-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6117445-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9938532-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5646156-A |
| priorityDate |
1992-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |